Compare SMTC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTC | CRL |
|---|---|---|
| Founded | 1960 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 8.3B |
| IPO Year | 1997 | 1999 |
| Metric | SMTC | CRL |
|---|---|---|
| Price | $89.93 | $178.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $77.53 | ★ $197.58 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.73 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $909,287,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $17.67 | $2.51 |
| Revenue Next Year | $14.49 | $4.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 4.67 | ★ 10.48 |
| 52 Week Low | $24.06 | $91.86 |
| 52 Week High | $93.96 | $228.88 |
| Indicator | SMTC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 61.35 | 47.38 |
| Support Level | $64.95 | $145.97 |
| Resistance Level | $92.50 | $182.81 |
| Average True Range (ATR) | 4.15 | 9.64 |
| MACD | 0.07 | 1.38 |
| Stochastic Oscillator | 64.56 | 77.01 |
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.